Publications
5891 Results
- Journal / Conference
- Haematologica 97(6):937-942
- Year
- 2012
- Research Committee(s)
- Lymphoma
- PMID
- PMID22271896
- PMC
- PMC3366663
- Study Number(s)
- SWOG-8809, S9800, S9911
Fc gamma receptor 3a genotype predicts overall survival for follicular lymphoma patients treated on Southwest Oncology Group trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone
- Journal / Conference
- The Oncologist 17(9):1180-1190;
- Year
- 2012
- Research Committee(s)
- Cancer Survivorship
- PMID
- PMID22723506
- PMC
- PMC3448411
- Study Number(s)
- S0316
A prospective analysis of the influence of older age on physician decision-making when considering enrollment to breast cancer clinical trials (SWOG S0316)
- Journal / Conference
- Cancer 118(3):770-776, 2012;
- Year
- 2012
- Research Committee(s)
- Sarcoma
- PMID
- PMID21751200
- PMC
- PMC3576704
- Study Number(s)
- S0505
Phase II SWOG-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas
- Journal / Conference
- International Journal of Radiation Oncology Biology Physics 82(2):809-816;
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID21277694
- PMC
- PMC3038247
- Study Number(s)
- R9704
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704 - a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas [PMID21277694; PMC3038247]
- Journal / Conference
- Journal of Clinical Oncology 30(19):2327-2333
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID2258569
- PMC
- PMC4517071
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Updated analysis of SWOG-directed Intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation following curative gastric resection (CALGB-9195; ECOG-6290; NCCTG-90-41; RTOG 9018 and SWOG-9008
- Journal / Conference
- International Journal of Medical Sciences 9(2):163-173;
- Year
- 2012
- Research Committee(s)
- Cancer Survivorship and Multiple sites
Cancer survivors in the United States: a call to action PMID:22275855; PMC:3264952
- Journal / Conference
- Investigational New Drugs 30(4):1646-1651
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID21748296
- PMC
- PMC3490705
- Study Number(s)
- S0514
SWOG 0514: A phase II study of sorafenib in patients with resectable or metastatic gallbladder carcinoma and cholangiocarcinoma [PMID21748296;PMC3490705]
- Journal / Conference
- International Journal Radiation Oncology Biology Physics 82(1):425-434
- Year
- 2012
- Research Committee(s)
- Lung
- PMID
- PMID20980108
- PMC
- NIHMSID250178
- Study Number(s)
- SWOG-8992 (RTOG-88-08) (ECOG-45-88)
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group [PMID:20980108; NIHMSID250178]
- Journal / Conference
- Journal of Urology 188(4):1164-1169;
- Year
- 2012
- Research Committee(s)
- Genitourinary
- PMID
- PMID22921015
- PMC
- PMC3481164
- Study Number(s)
- SWOG-8494 (INT-0036), SWOG-8894 (INT-0105) (EST-2889), SWOG-9346
Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 & S9346)
- Journal / Conference
- Leukemia & Lymphoma 53(2):259-262
- Year
- 2012
- Research Committee(s)
- Lymphoma
- PMID
- PMID21823829
- PMC
- PMC3477846
- Study Number(s)
- S0517